|
C5ORF51 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.030600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.630600E-01 |
| Normal-vs-Stage2 |
2.090600E-01 |
| Normal-vs-Stage3 |
3.322400E-01 |
| Normal-vs-Stage4 |
6.836400E-01 |
| Stage1-vs-Stage2 |
2.629000E-01 |
| Stage1-vs-Stage3 |
4.035400E-01 |
| Stage1-vs-Stage4 |
6.593000E-01 |
| Stage2-vs-Stage3 |
7.608200E-01 |
| Stage2-vs-Stage4 |
2.547000E-01 |
| Stage3-vs-Stage4 |
3.817800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.913400E-01 |
| Normal-vs-AfricanAmerican |
9.857400E-01 |
| Normal-vs-Asian |
3.208400E-01 |
| Caucasian-vs-AfricanAmerican |
5.365000E-01 |
| Caucasian-vs-Asian |
7.494800E-01 |
| AfricanAmerican-vs-Asian |
5.902000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.749000E-01 |
| Normal-vs-Female |
6.255800E-03 |
| Male-vs-Female |
2.722500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.182800E-01 |
| Normal-vs-Extreme_Weight |
4.198000E-01 |
| Normal-vs-Obese |
2.423600E-01 |
| Normal-vs-Extreme_Obese |
6.281800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.455800E-01 |
| Normal_Weight-vs-Obese |
5.699800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.708400E-01 |
| Extreme_Weight-vs-Obese |
7.819900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.222000E-01 |
| Obese-vs-Extreme_Obese |
3.480400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.584400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.190200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.217000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.982200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.487600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.618300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.751570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.187900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.036000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.668000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.488400E-01 |
| Normal-VS-Type2 PRCC |
2.197000E-01 |
| Normal-VS-KIRP CIMP |
7.272200E-01 |
| Normal-VS-Unclassified PRCC |
9.309500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.325440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.612600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.071700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.721000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.945600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.797000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.282600E-01 |
| Normal-vs-N1 |
1.019820E-01 |
| Normal-vs-N2 |
2.057000E-01 |
| N0-vs-N1 |
5.004200E-02 |
| N0-vs-N2 |
6.143000E-01 |
| N1-vs-N2 |
1.833400E-01 |
|
|
